Position in INSM
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$45,087,531
-$32,309,100 QoQ
Shares Held
275,731
-38.0% QoQ
Ownership
0.127%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in INSM Over Time
Shares Held
Position Value (USD)
Derivatives in INSM
reported options exposure · as of Dec 31, 2025CallValue
$3,654,840
CallShares
21,000
PutValue
$3,654,840
PutShares
21,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026BARCLAYS PLC holds $1,494,076,655 across 360 Biotechnology names. INSM ranks #5 (3.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
663,263 | $296,173,457 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
313,093 | $241,908,173 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
220,623 | $72,997,531 | |
| 4 | MRNA |
Moderna, Inc.
|
932,269 | $47,359,264 | |
| 5 | INSM |
INSMED Inc
This page
|
275,731 | $45,087,531 | |
| 6 | ROIV |
Roivant Sciences Ltd.
|
1,415,848 | $39,218,988 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
383,179 | $37,264,156 | |
| 8 | TERN |
Terns Pharmaceuticals, Inc.
|
669,601 | $35,301,364 |
All Filings in INSM
Export CSV
32 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $45,087,531 | 275,731 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $77,396,631 | 444,706 | Shares | Sole | 2026-02-13 | |
| 2025-12-31 | $3,654,840 | 21,000 | Call | Sole | 2026-02-13 | |
| 2025-12-31 | $3,654,840 | 21,000 | Put | Sole | 2026-02-13 | |
| 2025-09-30 | $3,024,210 | 21,000 | Call | Sole | 2026-03-31 | |
| 2025-09-30 | $16,445,365 | 114,196 | Shares | Sole | 2026-03-31 | |
| 2025-09-30 | $3,024,210 | 21,000 | Put | Sole | 2026-03-31 | |
| 2025-06-30 | $19,007,272 | 188,864 | Shares | Sole | 2026-02-27 | |
| 2025-03-31 | $21,305,508 | 279,270 | Shares | Sole | 2026-03-17 | |
| 2024-12-31 | $24,470,261 | 354,436 | Shares | Sole | 2026-03-19 | |
| 2024-09-30 | $24,240,599 | 332,063 | Shares | Sole | 2026-03-31 | |
| 2024-06-30 | $7,275,865 | 108,595 | Shares | Sole | 2026-03-23 | |
| 2024-06-30 | $4,576,100 | 68,300 | Call | Sole | 2026-03-23 | |
| 2024-03-31 | $1,486,724 | 54,800 | Call | Sole | 2026-03-24 | |
| 2024-03-31 | $6,183,903 | 227,936 | Shares | Sole | 2026-03-24 | |
| 2024-03-31 | $366,255 | 13,500 | Put | Sole | 2026-03-24 | |
| 2023-12-31 | $10,367,053 | 334,529 | Shares | Sole | 2026-03-24 | |
| 2023-09-30 | $4,337,975 | 171,801 | Shares | Sole | 2026-03-26 | |
| 2023-06-30 | $4,471,427 | 211,916 | Shares | Sole | 2026-03-27 | |
| 2023-03-31 | $15,974,827 | 936,940 | Shares | Sole | 2026-03-30 | |
| 2022-12-31 | $18,889,032 | 945,397 | Shares | Sole | 2026-03-30 | |
| 2022-09-30 | $9,134,058 | 424,051 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $7,159,779 | 363,072 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $514,838 | 21,908 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $3,904,990 | 143,355 | Shares | Sole | 2022-02-23 | |
| 2021-09-30 | $2,307,604 | 83,791 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $391,666 | 13,762 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $5,169,523 | 151,777 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $4,347,407 | 130,592 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $6,093,454 | 189,591 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $4,444,735 | 161,392 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $2,141,238 | 133,577 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||